Clinical Trial Update: Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the efficacy of HD6610 Granule for oxaliplatin-induced peripheral neuropathy in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oxaliplatin-induced Peripheral Neuropathy

Drugs mentioned

• HD6610 Granule

Snippet

Sponsor: Jiangsu Province Hospital of Traditional Chinese Medicine | Conditions: Peripheral Neuropathy | Phase 2, Phase 3 | Status: UNKNOWN